AllTranz Awarded $4 Million Research Grant by NIH and NIDA (Business Wire)
|
|
LEXINGTON, Ky.----AllTranz, Inc., a specialty pharmaceutical company focused on developing drugs to treat a variety of neurologic and inflammatory disorders, today announced that it has been awarded a $4 million research grant... [read full story]
View other selected articles:
jerseygirl908 says "If you like being without your meds you will love Caremark!" about CVS...
I am on chronic pain meds which have been impossible to find anywhere on the east coast since February of 2009. I used to be able to go to a pharmacy and get the meds no problem, but now I need to call my doctor, have the...
Luger Tony Benshoof's back woes are back again
Tony Benshoof, from the United States competes during men's World Cup luge in Calgary, Alberta, Saturday, Nov. 21, 2009. (AP Photo/The Canadian Press,Jeff McIntosh) By TIM REYNOLDS AP Sports Writer (AP) - Tony Benshoof's back...
Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of...
Raptor Pharmaceutical Corp. today announced the presentation of clinical trial data on NGX426, the Company's orally administered, non-opioid, AMPA/kainate receptor antagonist, at the 12th International Conference on the...
Exposures to metals and diesel emissions in air linked to respiratory symptoms in children
Exposure shortly after birth to ambient metals from residential heating oil combustion and particles from diesel emissions are associated with respiratory symptoms in young inner city children, according to a new study by...
International Editions
English - US | English - UK | Deutsch | Français | Español - España | Português - Portugal | Italiano | Čeština | Русский (Russian) | عربي (Arabic) | 中文（简）(Simplified Chinese) | Español - México | Português - Brasil | 한국어 (Korean) | English - India
